% alzhub.org library filter
% Source: https://alzhub.org/research?category=drug_development&journal=Nature+Reviews+Neurology
% 4 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{liu2021-34535787,
  author  = {Liu, K. Y. and Howard, R.},
  title   = {{Can we learn lessons from the FDA's approval of aducanumab?}},
  journal = {Nature reviews. Neurology},
  year    = {2021},
  doi     = {10.1038/s41582-021-00557-x},
  pmid    = {34535787},
  url     = {https://doi.org/10.1038/s41582-021-00557-x}
}

@article{llibreguerra2025-41184455,
  author  = {Llibre-Guerra, Jorge J and McDade, Eric M and Schindler, Suzanne E and Clifford, David B and Supnet, Charlene and Atri, Alireza and Bateman, Randall J},
  title   = {{Towards pharmacological prevention of Alzheimer disease}},
  journal = {Nature reviews. Neurology},
  year    = {2025},
  doi     = {10.1038/s41582-025-01154-y},
  pmid    = {41184455},
  url     = {https://doi.org/10.1038/s41582-025-01154-y}
}

@article{congdon2023-37875627,
  author  = {Congdon, E. E. and Ji, C. and Tetlow, A. M. and Jiang, Y. and Sigurdsson, E. M.},
  title   = {{Tau-targeting therapies for Alzheimer disease: current status and future directions}},
  journal = {Nature reviews. Neurology},
  year    = {2023},
  doi     = {10.1038/s41582-023-00883-2},
  pmid    = {37875627},
  url     = {https://doi.org/10.1038/s41582-023-00883-2}
}

@article{congdon2018-29895964,
  author  = {Congdon, E. E. and Sigurdsson, E. M.},
  title   = {{Tau-targeting therapies for Alzheimer disease}},
  journal = {Nature reviews. Neurology},
  year    = {2018},
  doi     = {10.1038/s41582-018-0013-z},
  pmid    = {29895964},
  url     = {https://doi.org/10.1038/s41582-018-0013-z}
}